40530 Federal Register / Vol. 62, No. 145 / Tuesday, July 29, 1997 / Notices

TRANSACTIONS GRANTED EARLY TERMINATION BETWEEN: 07/07/97 AND 07/18/97—Continued

Name of acquiring person, name of acquired person, name of acquired entity PMN No. Date

terminated

SIG plc, R.L. Anderson, Jr., Distribution International ..................................................................................................... 97–2715 07/15/97

Leo J. Hindery, Jr., Tele-Communications, Inc., Tele-Communications, Inc .................................................................. 97–2719 07/15/97

SAFECO Corporation, Lincoln National Corporation, American States Financial Corporation ...................................... 97–2724 07/15/97

Commercial Union plc, Charter Oak Partners, York Holding Company ......................................................................... 97–2729 07/15/97

Cheryl L. Thompson, Watson Electric Supply Company, Watson Electric Supply Company ........................................ 97–2733 07/15/97

Bindley Western Industries, Inc., James E. Richards, Tennessee Wholesale Drug Company, Inc. .............................. 97–2735 07/15/97

MasTec, Inc., Wilde Construction, Inc., Wilde Construction, Inc .................................................................................... 97–2737 07/15/97

Ronald A. Weinberg/Micheline Charest, Stephen T. Carson & Patricia L. Carson, Carson-Dellosa Publishing Company, Inc.; The Wild Goose .......................................................................................................................................... 97–2738 07/15/97

Torstar Corporation (a Canadian company), Mr. Jarret Schecter, Troll Communications, LLC ..................................... 97–2739 07/15/97

CRH plc, Lone Star Industries, Inc., New York Trap Rock Corporation ......................................................................... 97–2742 07/15/97

Harrowston, Inc., Anchor Lamina Inc., Anchor Lamina Inc ............................................................................................. 97–2619 07/16/97

Genesis Health Ventures, Inc., Genesis ElderCare Corp., Genesis ElderCare Corp .................................................... 97–2642 07/16/97

TPG Partners II, L.P., Genesis ElderCare Corp., Genesis ElderCare Corp ................................................................... 97–2643 07/16/97

Genesis Health Ventures, Inc., Genesis ElderCare Corp., The Multicare Companies ................................................... 97–2645 07/16/97

TPG Investors II, L.P., Genesis ElderCare Corporation, Genesis ElderCare Corporation ............................................. 97–2653 07/16/97

Edward K. Mullen, Daniel J. Sparler, Yorktowne Paper Mills, Inc.; Yorktowne Paper Mills of ....................................... 97–2676 07/16/97

Apollo Investment Fund III, L.P., Three Rivers Holding Corporation, Three Rivers Holding Corporation ...................... 97–2703 07/16/97

Cox Enterprises, Inc., H and P Radio, WBHJ, L.L.C., an Alabama Limited liability Company ...................................... 97–2736 07/16/97

Cypress Merchant Banking Partners, L.P., Genesis ElderCare Corp., Genesis ElderCare Corp .................................. 97–2644 07/17/97

USA Waste Services, Inc., David R. Kraemer, Edward Kraemer & Sons, Inc ............................................................... 97–1887 07/18/97

Clear Channel Communications, Inc., Triathlon Broadcasting Company, Triathlon Broadcasting of Little Rock, Inc ... 97–2126 07/18/97

AlliedSignal Inc., Grimes Partnership, L.P., FL Aerospace Holdings Corp ..................................................................... 97–2564 07/18/97

Intellicall, Inc., WorldCom, Inc., WorldCom, Inc .............................................................................................................. 97–2616 07/18/97

Cole National Corporation, Michael J. Rosenthal, American Vision Centers, Inc .......................................................... 97–2635 07/18/97

Cole National Corporation, The Fuji Bank, Limited, American Vision Centers, Inc ........................................................ 97–2636 07/18/97

Wolters Kluwer, nv, The Walt Disney Company, NILS Holding Company, Inc .............................................................. 97–2750 07/18/97

Key Energy Group, Inc., Nabors Industries, Inc., J.W. Gibson Well Service Company ................................................. 97–2755 07/18/97

ACX Technologies, Inc., Tetrafluor, Inc., Tetrafluor, Inc ................................................................................................. 97–2759 07/18/97

Reinhold Wurth, Winston L. Adams, Adams Nut and Bolt Co ........................................................................................ 97–2760 07/18/97

NationsBank Corporation, Michael Weintraub, Gibson Security Corp ............................................................................ 97–2761 07/18/97

Kenneth R. Thomson, Journal Printing Company of Stevens Point, Wisconsin, Journal Printing Company of Stevens

Point, Wisconsin ........................................................................................................................................................... 97–2762 07/18/97

Carrols Holdings Corporation, Richard D. Fors, Jr., see attached list ............................................................................ 97–2765 07/18/97

ERGON, Inc., Quaker State Corporation, Quaker State Corporation ............................................................................. 97–2767 07/18/97

Metal Management, Inc., Albert A. Cozzi, Cozzi Iron & Metal, Inc ................................................................................. 97–2769 07/18/97

Albert A. Cozzi, Metal Management, Inc., Metal Management, Inc ................................................................................ 97–2770 07/18/97

Frank J. Cozzi, Metal Management, Inc., Cozzi Iron & Metal, Inc .................................................................................. 97–2771 07/18/97

Argotyche, LP, Veda International Inc., Veda International Inc ...................................................................................... 97–2776 07/18/97

Hallmark Cards, Inc. Voting Trust dated 12/04/68, William A. DeJonge, William Arthur, Inc ........................................ 97–2777 07/18/97

Cook Inlet Region, Inc, Harry DeNardi, DeNardi Corporation; DeNardi Equipment Company ...................................... 97–2779 07/18/97

Lehman Brothers Holdings Inc., Harbourton Holdings, L.P., Harbourton Mortgage Co., L.P ........................................ 97–2780 07/18/97

Atlas Copco AB (jointly with) Prime Service, Inc., Robert Shanin, Norquip Rentals Corpor- artion/Assets ................... 97–2785 07/18/97

Lawrence J. Ellison, SuperGen, Inc., SuperGen, Inc ...................................................................................................... 97–2786 07/18/97

Whitney Equity Partners, L.P. , Lyonnaise des Eaux, Aqua-Chem. Inc ......................................................................... 97–2787 07/18/97

Bruckmann, Rosser, Sherrill & Co., L.P., PepsiCo, Inc., California Pizza Kitchen, Inc .................................................. 97–2788 07/18/97

American Radio Systems Corporation, Amaturo Group of California, Ltd., Amaturo Group of California, Ltd .............. 97–2794 07/18/97

A. Ahlstrom Corporation, H. Lynden Graham, Trustee for American Fiber Resources, American Fiber Resources,

L.P ................................................................................................................................................................................ 97–2815 07/18/97

FOR FURTHER INFORMATION CONTACT:

Sandra M. Peay or Parcellena P.

Fielding, Contact Representatives,

Federal Trade Commission, Premerger

Notification Office, Bureau of

Competition, Room 303, Washington,

D.C. 20580, (202) 326–3100.

By Direction of the Commission.

Benjamin I. Berman,

Acting Secretary.

[FR Doc. 97–19898 Filed 7–28–97; 8:45 am]

BILLING CODE 6750–01–M

FEDERAL TRADE COMMISSION

[Docket No. 9280]

Blue Coral, Inc.; Blue Coral-Slick 50,

Inc.; Blue Coral-Slick 50, Ltd.; Analysis

To Aid Public Comment

AGENCY: Federal Trade Commission.

ACTION: Proposed consent agreement.

SUMMARY: The consent agreement in this

matter settles alleged violations of

federal law prohibiting unfair or

deceptive acts or practices or unfair

methods of competition. The attached

Analysis to Aid Public Comment

describes both the allegations in the

draft amended complaint that

accompanies the consent agreement and

the terms of the consent order—

embodied in the consent agreement—

that would settle these allegations.

DATES: Comments must be received on

or before September 29, 1997.

ADDRESSES: Comments should be

directed to: FTC/Office of the Secretary,

Room 159, 6th St. and Pa. Ave., NW.,

Washington, DC 20580.

FOR FURTHER INFORMATION CONTACT:

Elaine D. Kolish, Federal Trade

Commission, S–4302, 6th &

Pennsylvania Ave., NW., Washington,

DC 20580. (202) 326–3042. Mary K.

Engle, Federal Trade Commission, S–
Federal Register / Vol. 62, No. 145 / Tuesday, July 29, 1997 / Notices 40531

4302, 6th & Pennsylvania Ave., NW.,

Washington, DC 20580; (202) 326–3161.

SUPPLEMENTARY INFORMATION: Pursuant

to Section 6(f) of the Federal Trade

Commission Act, 38 Stat. 721, 15 U.S.C.

46, and Section 3.25 of the

Commission’s Rules of Practice (16 CFR

3.25), notice is hereby given that the

above-captioned consent agreement

containing a consent order to cease and

desist, having been filed with and

accepted, subject to final approval, by

the Commission, has been placed on

public record for a period of sixty (60)

days. The following Analysis to Aid

Public Comment describes the terms of

the consent agreement, and the

allegations in the accompanying

complaint. An electronic copy of the

full text of the consent agreement

package can be obtained from the

Commission Actions section of the FTC

Home Page (for July 24, 1997), on the

World Wide Web, at ‘‘http://

www.ftc.gov/os/actions/htm.’’ A paper

copy can be obtained from the FTC

Public Reference Room, Room H–130,

Sixth Street and Pennsylvania Avenue,

NW., Washington, DC 20580, either in

person or by calling (202) 326–3627.

Public comment is invited. Such

comments or views will be considered

by the Commission and will be available

for inspection and copying at its

principal office in accordance with

Section 4.9(b)(6)(ii) of the Commission’s

Rules of Practice (16 CFR 4.9(b)(6)(ii)).

Analysis of Proposed Consent Order To

Aid Public Comment

The Federal Trade Commission has

accepted an agreement to a proposed

consent order from Blue Coral, Inc.;

Blue Coral-Slick 50, Inc.; and Blue

Coral-Slick 50, Ltd. These three entities

are successors in interest to Quaker

State—Slick 50, Inc.; Slick 50

Management, Inc.; Slick 50 Products

Corp.; and Slick 50 Corp. (all entities

collectively, ‘‘respondents’’).

The proposed consent order has been

placed on the public record for sixty

(60) days for receipt of comments by

interested persons. Comments received

during this period will become part of

the public record. After sixty (60) days,

the Commission will again review the

agreement and the comments received

and will decide whether it should

withdraw from the agreement or make

final the agreement’s proposed order.

This matter involves allegedly

deceptive representations for Slick 50

engine treatment, and aftermarket motor

oil additive containing particles of the

polymer polytetrafluoroethylene

(‘‘PTFE’’). The Commission issued a

complaint on July 12, 1996, charging

that advertisements for Slick 50

disseminated by the respondents made

various false and unsubstantiated

claims. The Commission’s complaint

was withdrawn from adjudication on

May 12, 1997, prior to commencement

of the administrative hearing, so that the

Commission could consider the

proposed order.

According to the FTC complaint, the

respondents falsely claimed: (1)

Automobile engines generally have little

or no protection from wear at or just

after start-up unless they have been

treated with Slick 50; (2) Automobile

engines commonly experience

premature failure caused by wear unless

they are treated with Slick 50; (3) Slick

50 coats engine parts with a layer of

PTFE; and (4) Slick 50 meets military

specifications for aftermarket motor oil

additives. The complaint alleged the

following claims as unsubstantiated: (1)

Compared to motor oil alone, Slick 50:

reduces engine wear, reduces engine

wear by more than 50%, reduces engine

wear by up to 50%, reduces engine wear

at start-up, extends the duration of

engine life, lowers engine temperatures,

reduces toxic emissions, increases gas

mileage, and increases horsepower; (2)

One treatment of Slick 50 continues to

reduce engine wear for 50,000 miles;

and (3) Slick 50 has been used in a

significant number of U.S. Government

vehicles. Lastly, the complaint alleged

that respondents falsely represented: (1)

Tests prove that, compared to motor oil

alone, Slick 50: reduces engine wear by

more than 50%, reduces engine wear by

up to 50%, and reduces engine wear at

start-up; and (2) Tests prove that one

treatment of Slick 50 continues to

reduce engine wear for 50,000 miles.

The proposed consent order contains

provisions designed to prevent the

respondents from engaging in similar

acts and practices in the future. Part I of

the proposed order prohibits the

respondents from representing that: (1)

Automobile engines generally have little

or no protection from wear at or just

after start-up unless they have been

treated with Slick 50 or a similar PTFE

product; (2) Automobile engines

commonly experience premature failure

caused by wear unless they are treated

with Slick 50 or a similar PTFE product;

or (3) Slick 50 or a similar PTFE product

coats engine parts with a layer of PTFE.

Part II of the proposed order prohibits

the respondents from misrepresenting

that any oil additive or Slick 50 engine

lubricating product meets the standards

of any organization and from

misrepresenting tests or studies when

selling such products. Part II also

prohibits the respondents from making

any representation about the

performance, benefits, efficacy,

attributes or use of such products

unless, at the time they make the

representation, they possess and rely

upon appropriate, competent and

reliable evidence that substantiates the

representation.

Part III of the proposed order

prohibits respondents from representing

that any Slick 50 lubricating product for

use in a motor vehicle, other than an

engine lubricating product, reduces

wear, extends the life of a part, lowers

engine temperature, reduces emissions,

or increases mileage or horsepower,

unless, at the time they make the

representation, they possess and rely

upon appropriate, competent and

reliable evidence that substantiates the

representation.

Parts IV through IX and XI require the

respondents to keep copies of

advertisements making representations

covered by the order; to keep records

concerning those representations;

including materials that they relied

upon when making the representations,

to notify the Commission of changes in

corporate structure; to provide copies of

the order to certain of respondents’

personnel; to send notice of the order to

purchasers for resale of Slick 50; to keep

records showing that the order or notice

of the order was received by or sent to

appropriate persons and showing any

redress made available to consumers

pursuant to class action lawsuits

challenging conduct similar to that

challenged in the Commission’s

complaint; to provide notice to

Commission staff prior to submitting

any proposed settlement of such class

action lawsuits to a court; and to file

with the Commission compliance

reports and reports showing any redress

made available to consumers pursuant

to class action lawsuits. Part X provides

that the order will terminate after

twenty (20) years under certain

circumstances.

Additionally, Paragraph 5 of the

consent agreement seeks to preserve the

Commission’s option to seek consumer

redress under Section 19 of the Federal

Trade Commission Act if the

respondents do not make available

redress having an aggregate retail value

of at least $10 million to consumers

pursuant to class action lawsuits that

challenge conduct similar to that

challenged in the Commission’s

complaint. Paragraph 5 also reserves the

Commission’s right to seek to intervene

in any such class action lawsuit to

oppose a settlement that it believes is

not in the public interest.

The purpose of this analysis is to

facilitate public comment on the

proposed order, and it is not intended

to constitute an official interpretation of
40532 Federal Register / Vol. 62, No. 145 / Tuesday, July 29, 1997 / Notices

the agreement and proposed order or to

modify in any way their terms.

Benjamin I. Berman,

Acting Secretary.

[FR Doc. 97–19897 Filed 7–28–97; 8:45 am]

BILLING CODE 6750–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Office of Public Health and Science;

Federal Policies Affecting the Future of

Academic Health Centers

AGENCY: Office of Public Health and

Science.

ACTION: Notice of two public hearings,

and comment.

SUMMARY: This notice announces that

the Secretary of Health and Human

Services is formally inviting public

comment on issues relevant to the

Department’s Initiative on the Future of

Academic Health Centers. The Secretary

has established an interagency policy

development group to review

Department policies affecting academic

health centers and other health

professions work force issues. The

policy development group will make

recommendations to the Secretary for

revising or implementing Federal

policies that ensure that the essential

public goods produced by academic

health centers are maintained in the

evolving health care system. These

essential public goods (health

professions education, biomedical and

other health research, and services to

vulnerable or disadvantaged

individuals, as well as special services,

i.e., trauma care, burn units, and

transplantation units), are critical to the

nation’s health care system.

The policy development group of the

Department’s initiative is interested in

gaining local and regional perspectives

from across the country on the issues

that surround the future of academic

health centers. To gain this input, two

national public hearings will be held.

These hearings will focus on issues

related to the future of education and

research missions of academic health

centers, the provision of services

through academic health centers, and

academic health centers’ need for access

to capital to achieve these missions.

Individuals may provide oral comments

regarding the future of academic health

centers, and Federal policies affecting

them. The testimony provided by key

stakeholders/constituents will be

considered in the development of

recommendations to the Secretary.

Written comments will also be accepted.

DATES: Two public hearings will be

held: August 25, 1997 in Houston, TX

and August 27, 1997 in Chicago, IL.

Requests to give oral testimony at the

hearings must be received in writing by

August 7, 1997. Written comments

accompanying oral testimony are due

August 11, 1997 for the August 25, 1997

hearing and on August 13, 1997 for the

August 27, 1997 hearing. Submission

deadline for written comments, without

oral testimony, is August 23, 1997.

ADDRESSES: Written requests to testify

and written comments on Federal

policies that impact the future of

academic health centers should be

submitted to: Ciro V. Sumaya, M.D.,

M.P.H.T.M., Deputy Assistant Secretary

for Health, Department of Health and

Human Services, Hubert H. Humphrey

Building, Room 716–G, 200

Independence Avenue, SW.,

Washington, DC 20201.

FOR FURTHER INFORMATION CONTACT: The

office of Dr. Sumaya at the address

listed above. Telephone: (202) 690–

7694. Facsimile: (202) 260–4405.

Electronic mail:

AHCInitiative@osophs.dhhs.gov

SUPPLEMENTARY INFORMATION:

Location Information

Sammons Auditorium, Texas Medical

Center Library, 1133 M.D. Anderson

Boulevard, Houston, Texas, 77030 on

August 25, 1997, 8:30 AM. Dirksen

Building, 219 S. Dearborne Street,

Courtroom #2541, Chicago, Illinois,

60604, on August 27, 1997, 8:30 AM.

Guidelines for Submitted Testimony

Those wishing to present written

testimony only should accompany their

testimony with an abstract that

summarizes their testimony in 200

words or less.

Those wishing to present oral

testimony should indicate the following

in their requests: (1) which of the two

public forums (Houston, Texas, August

25, 1997, or Chicago, Illinois, August 27,

1997) they would like to attend

depending upon availability; (2) the

type of institution or organization they

represent (academic health center or

school, professional association,

community organization, state/local

government, foundation, health plan,

insurer, other provider, or other), and

their mailing address, telephone

number, facsimile number, and

electronic mail address (if available).

Written comments may be longer than

the oral testimony presented. An

abstract that summarizes the testimony,

in 200 words or less, must accompany

the written testimony.

Both of these hearings will be limited

one day; therefore, it is possible that all

those who wish to present oral

testimony may not be accommodated.

Requests for oral presentations will be

honored on a first come, first serve

basis. Opportunity will be provided for

representation by a variety of

stakeholders/constituencies, as

identified above, as well as to ensure

geographic distribution. Oral comments

must be limited to no more than five

minutes. Presenters will be notified by

telephone if they will have the

opportunity to provide oral testimony,

with a follow-up confirmation in

writing.

Testimony Content Guidelines

Both public hearings will address

issues related to academic health

centers’ education and research

missions and the provision of health

care services (to under served

populations, and specialized services),

and related needs for access to capital

to support these public missions.

Written and oral testimony prepared

for these public hearings should address

one or more of these questions:

Education/Work Force

What role should academic health

centers play in developing the nation’s

health professions work force? What are

the current threats and barriers to

achieving those educational roles and

accompanying goals?

What Federal policies are needed to

improve academic health centers’

capacity to produce an appropriate

health professions work force at the

regional, state, and national level?

Is the use of consortia (e.g., hospital

networks, health professions schools) an

effective means to improve health

professions training and education? Are

there other models? Are specific

demonstrations and projects useful?

Research

What is the current status of the

nation’s health research enterprise (i.e.,

biomedical, clinical, behavioral, health

services, prevention/population based

research)?

What are some strategies for

maintaining a strong and productive

research infrastructure, including

training programs, support services, and

physical plants and operations?

What policies are needed to maintain

and improve the nation’s health

research capacity and productivity?

Services

Are services to vulnerable and under

served populations traditionally

provided by academic health centers at